Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2024 Earnings Call Transcript November 6, 2024
Trevi Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.12.
Operator: Good afternoon, and welcome to the Trevi Therapeutics Third Quarter 2024 Earnings Conference Call. At this time, all participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]...
